for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CRH Medical Corp

CRH.TO

Latest Trade

3.96CAD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

3.37

 - 

5.43

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
3.96
Open
--
Volume
--
3M AVG Volume
1.56
Today's High
--
Today's Low
--
52 Week High
5.43
52 Week Low
3.37
Shares Out (MIL)
72.03
Market Cap (MIL)
285.23
Forward P/E
38.29
Dividend (Yield %)
--

Latest Developments

More

CRH Medical Corporation Reports Q2 2019 Results

CRH Medical Corp Announces Majority Purchase Of Crystal River Anesthesia

CRH Medical Qtrly Total Revenue Of $29.1 Million

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology. The Company's product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company's CRH O'Regan System, platform that provides gastrointestinal is a single use, disposable, hemorrhoid banding technology for treating hemorrhoid grades I-IV. The Company distributes the CRH O'Regan System, treatment protocols, operational and marketing expertise as a package to physicians. The Company's subsidiary, Gastroenterology Anesthesia Associates, LLC, provides anesthesiology services for gastroenterology procedures.

Industry

Medical Equipment & Supplies

Contact Info

57B - 999 Canada Place

World Trade Center

+1.604.6331440

http://investors.crhsystem.com/

Executive Leadership

Anthony F. Holler

Independent Chairman of the Board

Tushar Ramani

Chief Executive Officer, Director

Richard K. Bear

Chief Financial Officer

Jay Kreger

President of CRH Anesthesia Management

David A Johnson

Independent Director

Key Stats

1.86 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.1K

2017

0.1K

2018

0.1K

2019(E)

0.1K
EPS (USD)

2016

0.147

2017

0.087

2018

0.063

2019(E)

0.078
Price To Earnings (TTM)
62.93
Price To Sales (TTM)
1.79
Price To Book (MRQ)
2.85
Price To Cash Flow (TTM)
4.78
Total Debt To Equity (MRQ)
88.86
LT Debt To Equity (MRQ)
85.52
Return on Investment (TTM)
7.73
Return on Equity (TTM)
5.22

Latest News

BRIEF-CRH Medical Corp Announces Majority Purchase Of Western Ohio Sedation Associates

* CRH MEDICAL CORPORATION ANNOUNCES MAJORITY PURCHASE OF WESTERN OHIO SEDATION ASSOCIATES Source text for Eikon: Further company coverage:

BRIEF-CRH Medical Corporation Q1 Revenue C$24.67 Million

* DURING Q1 OF 2018 COMPANY DID NOT ENTER INTO ANY MATERIAL CONTRACTS WITH COMMERCIAL PAYORS Source text for Eikon: Further company coverage:

BRIEF-Crh Medical Corp Announces 2017 Fourth Quarter And Year-End Results

* CRH MEDICAL CORPORATION ANNOUNCES 2017 FOURTH QUARTER AND YEAR-END RESULTS

BRIEF-CRH Medical receives TSX approval for normal course issuer bid

* CRH Medical receives TSX approval for normal course issuer bid

BRIEF-CRH Medical Corp says ‍total adj operating EBITDA will fall about 20 pct if CMS final rule applied to recent financial results​

* CRH Medical Corp - comments on centers for Medicare and Medicaid Services final 2018 physician fee schedule

BRIEF-CRH Medical Corp reports qtrly ‍total revenue $23.3 mln vs $22.1 mln​

* CRH Medical Corporation announces results for the three and nine months ended September 30, 2017

Ash Grove approves sale to CRH after Summit drop out

A majority of Ash Grove Cement's <ASHG.PK> shareholders approved the sale of the U.S. cement maker to Ireland's CRH <CRH.I> on Friday after a rival bid from Summit Materials <SUM.N> failed to materialize.

BRIEF-CRH Medical Corp expects Q3 total revenue of about US$22.7 mln​

* CRH Medical Corporation announces majority purchase of an anesthesia practice in North Carolina and provides an outlook for Q3 2017

BRIEF-CRH Medical Corp announces majority purchase of anesthesia practice in Central Colorado

* CRH Medical Corp announces majority purchase of anesthesia practice in Central Colorado Source text for Eikon: Further company coverage:

BRIEF-CRH Medical quarterly revenue C$22.06 mln vs C$16.59 mln

* CRH Medical Corporation announces results for the three and six months ended june 30, 2017

BRIEF-CRH Medical reports majority purchase of anesthesia practice in West Florida

* CRH Medical Corporation announces majority purchase of an anesthesia practice in West Florida Source text for Eikon: Further company coverage:

BRIEF-CRH Medical says new billing codes to be adopted by all commercial and federal payors effective Jan 1, 2018

* Crh medical corp - commented on estimated impact of center for medicare and medicaid services proposed fee schedule for 2018

BRIEF-CRH increases credit facility to $100 million

* CRH increases credit facility to US$100 million to fund additional growth and retire crown debt

BRIEF-CRH Medical Corp reports Q4 total revenue $25.8 million

* As at december 31, 2016, company had $9.5 million in cash and cash equivalents compared to $3.6 million at end of 2015 Source text for Eikon: Further company coverage:

BRIEF-CRH medical posts Q3 rev $22.1 mln

* Q3 revenue view $19.9 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-CRH Medical reports Q3 revenues of $22.11 mln

* Says revenues for three months ended september 30, 2016 were $22.11 million compared to $11.61 million last year Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up